Randomized phase II study of pemetrexed in combination with cisplatin or carboplatin as first-line chemotherapy in advanced non-small cell lung cancer.

被引：1
|
作者：
Nagel, S.
Groeschel, A.
Sebastian, M.
Andreas, S.
Mueller, T.
Schneller, F.
Guetz, S.
Leschinger, M. I.
Buettner, H.
Reck, M.
机构：
[1] Hosp Martha Maria, Dept Internal Med 2, Halle An Der Saale, Germany
[2] Univ Hosp Saarland, Homburg, Germany
[3] Univ Med Ctr, Dept Hematol Oncol & Pneumol, Mainz, Germany
[4] Ctr Pneumol, Lung Clin, Immenhausen, Germany
[5] Kliniken Main Taunus Kreises GmbH, Hosp Hofheim, Hofheim, Germany
[6] Tech Univ Munich, Policlin Klinikum Rechts Isar, Munich, Germany
[7] Robert Koch Clin Leipzig, Leipzig, Germany
[8] Lilly Deutschland GmbH, Dept Med, Bad Homburg, Germany
[9] Dept Pneumol & Thorac Surg, Grosshansdorf, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.7628
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7628
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A Randomized Phase II Study of Pemetrexed in Combination With Cisplatin or Carboplatin as First-Line Therapy for Patients With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer
    Schuette, Wolfgang H. W.
    Groeschel, Andreas
    Sebastian, Martin
    Andreas, Stefan
    Mueller, Thomas
    Schneller, Folker
    Guetz, Sylvia
    Eschbach, Corinna
    Bohnet, Sabine
    Leschinger, Monika I.
    Reck, Martin
    [J]. CLINICAL LUNG CANCER, 2013, 14 (03) : 215 - 223
  • [2] A randomized phase II trial of pemetrexed/gemcitabine/bevacizumab or pemetrexed/carboplatin/bevacizumab in the first-line treatment of elderly patients with advanced non-small cell lung cancer.
    Spigel, D. R.
    Greco, F. A.
    Shipley, D.
    Ervin, T. J.
    Lubiner, E. T.
    Peyton, J. D.
    Bames, E. K.
    Thompson, D. S.
    Burris, H. A., III
    Hainsworth, J. D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] A phase II trial of first-line bevacizumab in combination with pemetrexed and carboplatin in advanced nonsquamous non-small cell lung cancer (NSCLC)
    Skaff, Z. G.
    Hageboutros, A.
    Krieger, K.
    Coakley, S.
    Somer, R.
    Stevenson, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in advanced non-small cell lung cancer a multicenter, randomized, phase II trial
    Scagliotti, GV
    Kortsik, C
    Dark, GG
    Price, A
    Manegold, C
    Rosell, R
    O'Brien, M
    Peterson, PM
    Castellano, D
    Selvaggi, G
    Novello, S
    Blatter, J
    Kayitalire, L
    Crino, L
    Paz-Ares, L
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (02) : 690 - 696
  • [5] Phase II study of pemetrexed in combination with carboplatin in the first-line treatment of advanced nonsmall cell lung cancer
    Zinner, RG
    Fossella, FV
    Gladish, GW
    Glisson, BS
    Blumenschein, GR
    Papadimitrakopoulou, VA
    Pisters, KMW
    Kim, ES
    Yun, WH
    Peeples, BO
    Ye, ZS
    Curiel, RE
    Obasaju, CK
    Hong, WK
    Herbst, RS
    [J]. CANCER, 2005, 104 (11) : 2449 - 2456
  • [6] A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients with advanced non-squamous non-small cell lung cancer
    Motohiro Tamiya
    Akihiro Tamiya
    Hiroyasu Kaneda
    Kazuhiko Nakagawa
    Kiyotaka Yoh
    Koichi Goto
    Hiroaki Okamoto
    Tsuneo Shimokawa
    Tetsuya Abe
    Hiroshi Tanaka
    Haruko Daga
    Koji Takeda
    Tomonori Hirashima
    Shinji Atagi
    [J]. Medical Oncology, 2016, 33
  • [7] A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients with advanced non-squamous non-small cell lung cancer
    Tamiya, Motohiro
    Tamiya, Akihiro
    Kaneda, Hiroyasu
    Nakagawa, Kazuhiko
    Yoh, Kiyotaka
    Goto, Koichi
    Okamoto, Hiroaki
    Shimokawa, Tsuneo
    Abe, Tetsuya
    Tanaka, Hiroshi
    Daga, Haruko
    Takeda, Koji
    Hirashima, Tomonori
    Atagi, Shinji
    [J]. MEDICAL ONCOLOGY, 2016, 33 (01) : 1 - 7
  • [8] A Phase II Study of First-Line Chemotherapy with Weekly Carboplatin Plus Gemcitabine in Advanced Non-Small Cell Lung Cancer
    Mori, Kiyoshi
    Kamiyama, Yukari
    Kasai, Hisashi
    Kodama, Tetsuro
    [J]. CHEMOTHERAPY, 2012, 58 (01): : 78 - 83
  • [9] Phase II study of weekly carboplatin and irinotecan as first-line chemotherapy for patients with advanced non-small cell lung cancer
    Kim, Hyeong Su
    Kim, Jung Han
    Kim, Byounghoon
    Choi, Hyun Chang
    Kwon, Jung Hye
    Choi, Dae Ro
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (06) : 1591 - 1597
  • [10] Phase II study of weekly carboplatin and irinotecan as first-line chemotherapy for patients with advanced non-small cell lung cancer
    Hyeong Su Kim
    Jung Han Kim
    Byounghoon Kim
    Hyun Chang Choi
    Jung Hye Kwon
    Dae Ro Choi
    [J]. Cancer Chemotherapy and Pharmacology, 2013, 71 : 1591 - 1597
12345